Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Insmed Inc (INSM) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Insmed Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1104506.
Total stock buying since 2015: $5,031,928.
Total stock sales since 2015: $273,828,717.
Total stock option exercises since 2015: $66,309,842.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 3,025 | $201,693 | 1,504,618 | $143,375,574 | 875,541 | $16,500,517 |
| 2024 | 0 | $0 | 1,128,148 | $61,564,587 | 1,004,746 | $21,392,228 |
| 2023 | 20,000 | $385,800 | 239,551 | $5,655,247 | 374,734 | $5,181,828 |
| 2022 | 95,000 | $1,667,650 | 462,351 | $11,801,151 | 410,028 | $3,922,511 |
| 2021 | 26,945 | $830,541 | 465,856 | $15,542,968 | 470,565 | $5,288,424 |
| 2020 | 0 | $0 | 498,068 | $16,761,705 | 528,722 | $4,465,965 |
| 2019 | 0 | $0 | 465,386 | $11,967,509 | 321,070 | $7,637,153 |
| 2018 | 54,785 | $871,762 | 37,575 | $1,054,630 | 37,575 | $407,688 |
| 2017 | 10,000 | $151,382 | 130,000 | $3,525,275 | 90,000 | $381,300 |
| 2016 | 70,000 | $923,100 | 120,240 | $1,564,811 | 118,774 | $816,791 |
| 2015 | 0 | $0 | 43,750 | $1,015,260 | 25,184 | $315,437 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-09 | 0 | $0 | 210,920 | $30,297,118 | 199,428 | $5,000,416 |
| 2025-08 | 0 | $0 | 77,410 | $9,568,817 | 22,410 | $320,624 |
| 2025-07 | 0 | $0 | 131,505 | $13,081,521 | 109,436 | $2,732,150 |
| 2025-06 | 0 | $0 | 467,189 | $44,107,498 | 385,877 | $5,914,957 |
| 2025-05 | 3,025 | $201,693 | 124,044 | $8,425,411 | 13,660 | $148,210 |
| 2025-04 | 0 | $0 | 6,830 | $481,426 | 6,830 | $74,105 |
| 2025-03 | 0 | $0 | 51,160 | $3,980,196 | 51,160 | $859,742 |
| 2025-02 | 0 | $0 | 300,853 | $24,318,288 | 25,580 | $429,871 |
| 2025-01 | 0 | $0 | 134,707 | $9,115,299 | 61,160 | $1,020,442 |
| 2024-12 | 0 | $0 | 51,160 | $3,672,648 | 51,160 | $859,742 |
| 2024-09 | 0 | $0 | 255,488 | $18,516,167 | 234,617 | $5,348,924 |
| 2024-08 | 0 | $0 | 97,539 | $7,133,131 | 88,070 | $1,413,259 |
| 2024-06 | 0 | $0 | 76,195 | $4,314,850 | 76,195 | $1,571,206 |
| 2024-05 | 0 | $0 | 525,422 | $24,356,139 | 439,010 | $10,251,727 |
| 2024-02 | 0 | $0 | 0 | $0 | 50,000 | $629,000 |
| 2024-01 | 0 | $0 | 122,344 | $3,571,652 | 65,694 | $1,318,370 |
| 2023-12 | 0 | $0 | 41,509 | $1,245,270 | 28,310 | $669,814 |
| 2023-10 | 0 | $0 | 112,000 | $2,803,920 | 112,500 | $1,602,000 |
| 2023-07 | 0 | $0 | 740 | $14,933 | 0 | $0 |
| 2023-06 | 0 | $0 | 17,849 | $344,398 | 0 | $0 |
| 2023-05 | 20,000 | $385,800 | 46,698 | $872,871 | 233,924 | $2,910,014 |
| 2023-01 | 0 | $0 | 20,755 | $373,855 | 0 | $0 |
| 2022-11 | 10,000 | $177,000 | 0 | $0 | 0 | $0 |
| 2022-10 | 65,000 | $1,146,650 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-09-02 | Smith Michael Alexander (Chief Legal Officer) | Sale | 24,272 | 143.60 | 3,485,507 |
| 2025-09-02 | Smith Michael Alexander (Chief Legal Officer) | Option Ex | 12,780 | 30.46 | 389,278 |
| 2025-09-02 | Flammer Martina M.d. (Chief Medical Officer) | Sale | 186,648 | 143.65 | 26,811,611 |
| 2025-09-02 | Flammer Martina M.d. (Chief Medical Officer) | Option Ex | 186,648 | 24.70 | 4,611,138 |
| 2025-08-20 | Sharoky Melvin Md (Director) | Sale | 10,000 | 129.50 | 1,295,000 |
| 2025-08-19 | Adsett Roger (Chief Operating Officer) | Sale | 25,000 | 127.84 | 3,196,125 |
| 2025-08-18 | Lewis William (Chair and CEO) | Sale | 6,865 | 128.61 | 882,887 |
| 2025-08-18 | Lewis William (Chair and CEO) | Option Ex | 6,865 | 10.85 | 74,485 |
| 2025-08-14 | Schaeffer Orlov S Nicole (Chief People Strategy Officer) | Sale | 10,000 | 127.48 | 1,274,800 |
| 2025-08-12 | Sharoky Melvin Md (Director) | Sale | 10,000 | 121.58 | 1,215,800 |
| 2025-08-04 | Flammer Martina M.d. (Chief Medical Officer) | Sale | 8,715 | 109.50 | 954,292 |
| 2025-08-04 | Flammer Martina M.d. (Chief Medical Officer) | Option Ex | 8,715 | 19.74 | 172,034 |
| 2025-08-04 | Lewis William (Chair and CEO) | Sale | 6,830 | 109.80 | 749,913 |
| 2025-08-04 | Lewis William (Chair and CEO) | Option Ex | 6,830 | 10.85 | 74,105 |
| 2025-07-21 | Bonstein Sara (Chief Financial Officer) | Sale | 58,400 | 102.70 | 5,997,972 |
| 2025-07-21 | Bonstein Sara (Chief Financial Officer) | Option Ex | 47,888 | 29.62 | 1,418,682 |
| 2025-07-15 | Smith Michael Alexander (Chief Legal Officer) | Sale | 933 | 102.51 | 95,641 |
| 2025-07-15 | Lewis William (Chair and CEO) | Sale | 6,830 | 102.56 | 700,505 |
| 2025-07-15 | Lewis William (Chair and CEO) | Option Ex | 6,830 | 10.85 | 74,105 |
| 2025-07-11 | Smith Michael Alexander (Chief Legal Officer) | Sale | 748 | 96.41 | 72,114 |
| 2025-07-07 | Bonstein Sara (Chief Financial Officer) | Sale | 57,764 | 95.92 | 5,541,011 |
| 2025-07-07 | Bonstein Sara (Chief Financial Officer) | Option Ex | 47,888 | 24.33 | 1,165,258 |
| 2025-07-01 | Lewis William (Chair and CEO) | Sale | 6,830 | 98.72 | 674,278 |
| 2025-07-01 | Lewis William (Chair and CEO) | Option Ex | 6,830 | 10.85 | 74,105 |
| 2025-06-23 | Bonstein Sara (Chief Financial Officer) | Sale | 57,765 | 101.93 | 5,887,986 |
| 2025-06-23 | Bonstein Sara (Chief Financial Officer) | Option Ex | 47,889 | 19.34 | 926,412 |
| 2025-06-16 | Adsett Roger (Chief Operating Officer) | Sale | 10,686 | 98.91 | 1,056,952 |
| 2025-06-16 | Lewis William (Chair and CEO) | Sale | 135,009 | 100.00 | 13,501,440 |
| 2025-06-16 | Lewis William (Chair and CEO) | Option Ex | 129,805 | 10.85 | 1,408,384 |
| 2025-06-11 | Flammer Martina M.d. (Chief Medical Officer) | Sale | 19,423 | 94.50 | 1,835,473 |
| 2025-06-11 | Flammer Martina M.d. (Chief Medical Officer) | Option Ex | 19,423 | 17.07 | 331,550 |
| 2025-06-11 | Schaeffer Orlov S Nicole (Chief People Strategy Officer) | Sale | 99,172 | 93.88 | 9,310,267 |
| 2025-06-11 | Schaeffer Orlov S Nicole (Chief People Strategy Officer) | Option Ex | 70,000 | 13.91 | 973,700 |
| 2025-06-10 | Flammer Martina M.d. (Chief Medical Officer) | Sale | 25,740 | 88.64 | 2,281,593 |
| 2025-06-10 | Flammer Martina M.d. (Chief Medical Officer) | Option Ex | 25,740 | 26.46 | 681,080 |
| 2025-06-10 | Bonstein Sara (Chief Financial Officer) | Sale | 57,766 | 89.47 | 5,168,497 |
| 2025-06-10 | Bonstein Sara (Chief Financial Officer) | Option Ex | 47,890 | 18.01 | 862,498 |
| 2025-06-10 | Schaeffer Orlov S Nicole (Chief People Strategy Officer) | Sale | 38,300 | 88.64 | 3,394,912 |
| 2025-06-10 | Schaeffer Orlov S Nicole (Chief People Strategy Officer) | Option Ex | 38,300 | 17.16 | 657,228 |
| 2025-06-04 | Mcgirr David W J | Sale | 3,000 | 73.27 | 219,810 |
| 2025-06-03 | Smith Michael Alexander (Chief Legal Officer) | Sale | 1,448 | 71.50 | 103,532 |
| 2025-06-03 | Flammer Martina M.d. (Chief Medical Officer) | Sale | 1,686 | 71.50 | 120,549 |
| 2025-06-03 | Lewis William (Chair and CEO) | Sale | 5,472 | 71.50 | 391,248 |
| 2025-06-03 | Schaeffer Orlov S Nicole (Chief People Strategy Officer) | Sale | 1,642 | 71.50 | 117,403 |
| 2025-06-03 | Mcgirr David W J | Sale | 3,250 | 71.30 | 231,725 |
| 2025-06-02 | Lewis William (Chair and CEO) | Sale | 6,830 | 71.17 | 486,111 |
| 2025-06-02 | Lewis William (Chair and CEO) | Option Ex | 6,830 | 10.85 | 74,105 |
| 2025-05-30 | Smith Michael Alexander (Chief Legal Officer) | Sale | 26,327 | 69.28 | 1,823,934 |
| 2025-05-21 | Desjardins Clarissa | Buy | 1,130 | 66.35 | 74,975 |
| 2025-05-20 | Desjardins Clarissa | Buy | 1,895 | 66.87 | 126,718 |
| 2025-05-20 | Lewis William (Chair and CEO) | Sale | 27,887 | 67.81 | 1,891,156 |
| 2025-05-20 | Lewis William (Chair and CEO) | Option Ex | 6,830 | 10.85 | 74,105 |
| 2025-05-16 | Flammer Martina M.d. (Chief Medical Officer) | Sale | 1,799 | 67.53 | 121,486 |
| 2025-05-15 | Flammer Martina M.d. (Chief Medical Officer) | Sale | 9,925 | 65.47 | 649,789 |
| 2025-05-14 | Flammer Martina M.d. (Chief Medical Officer) | Sale | 1,744 | 65.61 | 114,423 |
| 2025-05-14 | Adsett Roger (Chief Operating Officer) | Sale | 1,925 | 65.61 | 126,299 |
| 2025-05-14 | Bonstein Sara (Chief Financial Officer) | Sale | 1,634 | 65.61 | 107,206 |
| 2025-05-14 | Lewis William (Chair and CEO) | Sale | 3,771 | 65.61 | 247,415 |
| 2025-05-13 | Flammer Martina M.d. (Chief Medical Officer) | Sale | 8,408 | 67.81 | 570,146 |
| 2025-05-13 | Adsett Roger (Chief Operating Officer) | Sale | 7,482 | 67.81 | 507,354 |
| 2025-05-13 | Bonstein Sara (Chief Financial Officer) | Sale | 8,870 | 67.81 | 601,474 |
| 2025-05-13 | Lewis William (Chair and CEO) | Sale | 17,442 | 67.05 | 1,169,486 |
| 2025-05-01 | Lewis William (Chair and CEO) | Sale | 6,830 | 72.51 | 495,243 |
| 2025-05-01 | Lewis William (Chair and CEO) | Option Ex | 6,830 | 10.85 | 74,105 |
| 2025-04-15 | Lewis William (Chair and CEO) | Sale | 6,830 | 70.49 | 481,426 |
| 2025-04-15 | Lewis William (Chair and CEO) | Option Ex | 6,830 | 10.85 | 74,105 |
| 2025-03-17 | Lewis William (Chair and CEO) | Sale | 25,580 | 76.90 | 1,967,153 |
| 2025-03-17 | Lewis William (Chair and CEO) | Option Ex | 25,580 | 16.80 | 429,871 |
| 2025-03-03 | Lewis William (Chair and CEO) | Sale | 25,580 | 78.70 | 2,013,043 |
| 2025-03-03 | Lewis William (Chair and CEO) | Option Ex | 25,580 | 16.80 | 429,871 |
| 2025-02-18 | Bonstein Sara (Chief Financial Officer) | Sale | 18,322 | 80.64 | 1,477,486 |
| 2025-02-18 | Lewis William (Chair and CEO) | Sale | 25,580 | 80.93 | 2,070,189 |
| 2025-02-18 | Lewis William (Chair and CEO) | Option Ex | 25,580 | 16.80 | 429,871 |
| 2025-02-12 | Bonstein Sara (Chief Financial Officer) | Sale | 5,019 | 80.00 | 401,520 |
| 2025-02-11 | Bonstein Sara (Chief Financial Officer) | Sale | 13,302 | 80.00 | 1,064,160 |
| 2025-02-07 | Wise John Drayton (Chief Commercial Officer) | Sale | 10 | 78.91 | 789 |
| 2025-02-07 | Flammer Martina M.d. (Chief Medical Officer) | Sale | 60 | 79.59 | 4,775 |
| 2025-02-07 | Adsett Roger (Chief Operating Officer) | Sale | 100 | 79.57 | 7,956 |
| 2025-02-06 | Wise John Drayton (Chief Commercial Officer) | Sale | 7,910 | 80.90 | 639,919 |
| 2025-02-06 | Smith Michael Alexander (Chief Legal Officer) | Sale | 20,650 | 80.90 | 1,670,585 |
| 2025-02-06 | Flammer Martina M.d. (Chief Medical Officer) | Sale | 33,055 | 80.90 | 2,674,149 |
| 2025-02-06 | Adsett Roger (Chief Operating Officer) | Sale | 45,605 | 80.90 | 3,689,444 |
| 2025-02-06 | Bonstein Sara (Chief Financial Officer) | Sale | 28,390 | 80.90 | 2,296,751 |
| 2025-02-06 | Lewis William (Chair and CEO) | Sale | 79,350 | 80.90 | 6,419,415 |
| 2025-02-06 | Schaeffer Orlov S Nicole (Chief People Strategy Officer) | Sale | 23,500 | 80.90 | 1,901,150 |
| 2025-01-15 | Lewis William (Chair and CEO) | Sale | 38,635 | 70.25 | 2,713,992 |
| 2025-01-15 | Lewis William (Chair and CEO) | Option Ex | 25,580 | 16.80 | 429,871 |
| 2025-01-14 | Flammer Martina M.d. (Chief Medical Officer) | Sale | 1,384 | 68.72 | 95,108 |
| 2025-01-14 | Adsett Roger (Chief Operating Officer) | Sale | 1,457 | 68.72 | 100,125 |
| 2025-01-14 | Schaeffer Orlov S Nicole (Chief People Strategy Officer) | Sale | 872 | 68.72 | 59,923 |
| 2025-01-10 | Wise John Drayton (Chief Commercial Officer) | Sale | 287 | 65.40 | 18,769 |
| 2025-01-10 | Smith Michael Alexander (Chief Legal Officer) | Sale | 319 | 63.38 | 20,218 |
| 2025-01-10 | Flammer Martina M.d. (Chief Medical Officer) | Sale | 6,172 | 63.67 | 393,002 |
| 2025-01-10 | Adsett Roger (Chief Operating Officer) | Sale | 4,902 | 63.74 | 312,453 |
| 2025-01-10 | Bonstein Sara (Chief Financial Officer) | Sale | 1,066 | 63.72 | 67,925 |
| 2025-01-10 | Lewis William (Chair and CEO) | Sale | 2,978 | 63.36 | 188,686 |
| 2025-01-10 | Schaeffer Orlov S Nicole (Chief People Strategy Officer) | Sale | 4,057 | 63.74 | 258,613 |
| 2025-01-08 | Wise John Drayton (Chief Commercial Officer) | Sale | 392 | 66.21 | 25,954 |
| 2025-01-08 | Smith Michael Alexander (Chief Legal Officer) | Sale | 1,064 | 66.21 | 70,447 |
| 2025-01-08 | Flammer Martina M.d. (Chief Medical Officer) | Sale | 1,702 | 66.16 | 112,604 |
| 2025-01-08 | Adsett Roger (Chief Operating Officer) | Sale | 1,882 | 66.10 | 124,400 |
| 2025-01-08 | Bonstein Sara (Chief Financial Officer) | Sale | 1,464 | 66.05 | 96,697 |
| 2025-01-08 | Lewis William (Chair and CEO) | Sale | 3,999 | 65.96 | 263,774 |
| 2025-01-08 | Schaeffer Orlov S Nicole (Chief People Strategy Officer) | Sale | 1,209 | 65.84 | 79,600 |
| 2025-01-07 | Wise John Drayton (Chief Commercial Officer) | Sale | 12,908 | 65.92 | 850,959 |
| 2025-01-07 | Wise John Drayton (Chief Commercial Officer) | Option Ex | 10,000 | 16.07 | 160,700 |
| 2025-01-07 | Smith Michael Alexander (Chief Legal Officer) | Sale | 2,306 | 65.98 | 152,149 |
| 2025-01-07 | Flammer Martina M.d. (Chief Medical Officer) | Sale | 3,344 | 65.91 | 220,403 |
| 2025-01-07 | Adsett Roger (Chief Operating Officer) | Sale | 2,444 | 65.95 | 161,181 |
| 2025-01-07 | Bonstein Sara (Chief Financial Officer) | Sale | 3,470 | 65.70 | 227,979 |
| 2025-01-07 | Lewis William (Chair and CEO) | Sale | 8,218 | 66.02 | 542,552 |
| 2025-01-07 | Schaeffer Orlov S Nicole (Chief People Strategy Officer) | Sale | 2,596 | 65.88 | 171,024 |
| 2025-01-02 | Lewis William (Chair and CEO) | Sale | 25,580 | 69.85 | 1,786,762 |
| 2025-01-02 | Lewis William (Chair and CEO) | Option Ex | 25,580 | 16.80 | 429,871 |
| 2024-12-19 | Lewis William (Chair and CEO) | Sale | 25,580 | 70.12 | 1,793,746 |
| 2024-12-19 | Lewis William (Chair and CEO) | Option Ex | 25,580 | 16.80 | 429,871 |
| 2024-12-12 | Lewis William (Chair and CEO) | Sale | 25,580 | 73.45 | 1,878,902 |
| 2024-12-12 | Lewis William (Chair and CEO) | Option Ex | 25,580 | 16.80 | 429,871 |
| 2024-09-16 | Flammer Martina M.d. (Chief Medical Officer) | Sale | 13,436 | 74.92 | 1,006,625 |
| 2024-09-16 | Flammer Martina M.d. (Chief Medical Officer) | Option Ex | 13,436 | 34.03 | 457,227 |
| 2024-09-13 | Smith Michael Alexander (Chief Legal Officer) | Sale | 27,871 | 74.45 | 2,075,135 |
| 2024-09-13 | Smith Michael Alexander (Chief Legal Officer) | Option Ex | 7,000 | 22.76 | 159,320 |
| 2024-09-13 | Flammer Martina M.d. (Chief Medical Officer) | Sale | 26,969 | 74.90 | 2,019,978 |
| 2024-09-13 | Flammer Martina M.d. (Chief Medical Officer) | Option Ex | 26,969 | 34.03 | 917,755 |
| 2024-09-12 | Flammer Martina M.d. (Chief Medical Officer) | Sale | 635 | 74.92 | 47,574 |
| 2024-09-12 | Flammer Martina M.d. (Chief Medical Officer) | Option Ex | 635 | 34.03 | 21,609 |
| 2024-09-10 | Schaeffer Orlov S Nicole (Chief People Strategy Officer) | Sale | 37,575 | 71.62 | 2,691,309 |
| 2024-09-10 | Schaeffer Orlov S Nicole (Chief People Strategy Officer) | Option Ex | 37,575 | 10.85 | 407,688 |
| 2024-09-06 | Flammer Martina M.d. (Chief Medical Officer) | Sale | 149,002 | 71.65 | 10,675,546 |
| 2024-09-06 | Flammer Martina M.d. (Chief Medical Officer) | Option Ex | 149,002 | 22.72 | 3,385,325 |
| 2024-08-12 | Smith Michael Alexander (Chief Legal Officer) | Sale | 88,070 | 73.20 | 6,446,724 |
| 2024-08-12 | Smith Michael Alexander (Chief Legal Officer) | Option Ex | 88,070 | 16.05 | 1,413,259 |
| 2024-08-12 | Schaeffer Orlov S Nicole (Chief People Strategy Officer) | Sale | 9,469 | 72.49 | 686,407 |
| 2024-06-10 | Flammer Martina M.d. (Chief Medical Officer) | Sale | 21,195 | 60.00 | 1,271,700 |
| 2024-06-10 | Flammer Martina M.d. (Chief Medical Officer) | Option Ex | 21,195 | 23.75 | 503,381 |
| 2024-06-03 | Schaeffer Orlov S Nicole (Chief People Strategy Officer) | Sale | 55,000 | 55.33 | 3,043,150 |
| 2024-06-03 | Schaeffer Orlov S Nicole (Chief People Strategy Officer) | Option Ex | 55,000 | 19.41 | 1,067,825 |
| 2024-05-30 | Flammer Martina M.d. (Chief Medical Officer) | Sale | 21,195 | 55.00 | 1,165,725 |
| 2024-05-30 | Flammer Martina M.d. (Chief Medical Officer) | Option Ex | 21,195 | 23.75 | 503,381 |
| 2024-05-29 | Bonstein Sara (Chief Financial Officer) | Sale | 220,564 | 50.00 | 11,028,200 |
| 2024-05-29 | Bonstein Sara (Chief Financial Officer) | Option Ex | 220,564 | 26.26 | 5,792,451 |
| 2024-05-28 | Wise John Drayton (Chief Commercial Officer) | Sale | 7,852 | 49.48 | 388,477 |
| 2024-05-28 | Wise John Drayton (Chief Commercial Officer) | Option Ex | 6,250 | 12.58 | 78,625 |
| 2024-05-28 | Smith Michael Alexander (Chief Legal Officer) | Sale | 44,722 | 49.53 | 2,215,080 |
| 2024-05-28 | Smith Michael Alexander (Chief Legal Officer) | Option Ex | 38,971 | 13.63 | 531,018 |
| 2024-05-28 | Flammer Martina M.d. (Chief Medical Officer) | Sale | 103,806 | 49.62 | 5,150,853 |
| 2024-05-28 | Flammer Martina M.d. (Chief Medical Officer) | Option Ex | 103,806 | 23.66 | 2,456,049 |
| 2024-05-28 | Bonstein Sara (Chief Financial Officer) | Sale | 20,724 | 50.01 | 1,036,407 |
| 2024-05-28 | Bonstein Sara (Chief Financial Officer) | Option Ex | 20,724 | 26.26 | 544,253 |
| 2024-05-28 | Schaeffer Orlov S Nicole (Chief People Strategy Officer) | Sale | 27,500 | 49.53 | 1,362,075 |
Insider trading activities including stock purchases, stock sales, and option exercises of INSM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Insmed Inc (symbol INSM, CIK number 1104506) see the Securities and Exchange Commission (SEC) website.